{"database": "openregs", "table": "documents", "rows": [["FDA-2015-D-4380-0001", "FDA", "FDA-2015-D-4380", "Best Practices for Communication Between Investigational New Drug\nSponsors and Food and Drug Administration During Drug Development; Draft Guidance for Industry and Review Staff; Availability", "Notice", "Notice of Availability", "2015-12-09T05:00:00Z", 2015, 12, "2015-12-09T05:00:00Z", "2016-02-09T04:59:59Z", "2016-02-08T22:00:59Z", "2015-30931", 0, 0, "0900006481d9267b"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-D-4380-0001"], "units": {}, "query_ms": 0.3296670038253069, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}